ArticleMolecular biology reports2024

Ribosomal protein S6 kinase 2 (RPS6KB2) is a potential immunotherapeutic target for cancer that upregulates proinflammatory cytokines.

Qiang Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.